Literature DB >> 7684342

Evidence for the participation of protein kinase C and 3',5'-cyclic AMP-dependent protein kinase in the stimulation of muscle cell proliferation by 1,25-dihydroxy-vitamin D3.

T Bellido1, S Morelli, L M Fernández, R Boland.   

Abstract

Treatment with 1,25-dihydroxy-vitamin D3 (1,25(OH)2D3) (1-12 h, 10(-10) M) stimulates DNA synthesis in proliferating myoblasts, with an early response at 2-4 h of treatment followed by a maximal effect at 10 h. To investigate the mechanism involved in the mitogenic action of the hormone we studied the possible activation of intracellular messengers by 1,25(OH)2D3. The initial phase of stimulation of [3H]thymidine incorporation into DNA by the sterol was mimicked by the protein kinase C activator tetradecanoylphorbol acetate (TPA) in a manner which was dose dependent and specific as the inactive analog 4 alpha-phorbol was without effect. Maximal responses to TPA (100 nM) were obtained at 4 h. Staurosporine, a protein kinase C inhibitor, blocked the effect of 1,25(OH)2D3 on myoblast proliferation at 4 h. In addition, a fast (1-5 min) elevation of diacylglycerol levels and membrane-associated protein kinase C activity was observed in response to 1,25(OH)2D3. The adenylate cyclase activator forskolin (20 microM) and dibutyryl-cAMP (50 microM) increased DNA synthesis reproducing the second 1,25(OH)2D3-dependent stimulatory phase at 10 h. Inhibitors of protein kinase A blocked the increase in muscle cell DNA synthesis induced by 1,25(OH)2D3 at 10 h. Significant increases in cyclic AMP levels were detected in myoblasts treated with the sterol for 1-10 h. The calcium channel antagonist nifedipine (5-10 microM) abolished both the effects of 4-h treatment with 1,25(OH)2D3 or TPA and 10-h treatment with 1,25(OH)2D3 or dibutyryl-cAMP. Similar to the calcium channel agonist Bay K8644, 1,25(OH)2D3 stimulated myoblast 45Ca uptake and its effects were blocked by nifedipine.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7684342     DOI: 10.1016/0303-7207(93)90156-e

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  5 in total

1.  Rapid actions of calcitriol and its side chain analogues CB1093 and GS1500 on intracellular calcium levels in skeletal muscle cells: a comparative study.

Authors:  G Vazquez; J Sellés; A R de Boland; R Boland
Journal:  Br J Pharmacol       Date:  1999-04       Impact factor: 8.739

2.  Regulatory effect of 1,25-dihydroxyvitamin D3 on insulin release and calcium handling via the phospholipid pathway in islets from vitamin D-deficient rats.

Authors:  B J Billaudel; P M Bourlon; B C Sutter; A G Faure-Dussert
Journal:  J Endocrinol Invest       Date:  1995-10       Impact factor: 4.256

3.  Redox regulation of cAMP levels by ascorbate in 1,25-dihydroxy- vitamin D3-induced differentiation of HL-60 cells.

Authors:  G López-Lluch; M I Burón; F J Alcaín; J M Quesada; P Navas
Journal:  Biochem J       Date:  1998-04-01       Impact factor: 3.857

Review 4.  A novel vitamin D-regulated immediate-early gene, IEX-1, alters cellular growth and apoptosis.

Authors:  Rajiv Kumar; Mark R Pittelkow; Jeffrey L Salisbury; Joseph P Grande; Hee-Jeong Im; Kathrin A Feldmann; David Schilling
Journal:  Recent Results Cancer Res       Date:  2003

Review 5.  Mechanistic Effects of Calcitriol in Cancer Biology.

Authors:  Lorenza Díaz; Mauricio Díaz-Muñoz; Ana Cristina García-Gaytán; Isabel Méndez
Journal:  Nutrients       Date:  2015-06-19       Impact factor: 5.717

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.